No Data
No Data
Express News | MindMed Appoints Javier Muniz, M.d., as Vice President of Research and Development Strategy
MindMed Announces New Employee Inducement Grants
RBC Capital Maintains Mind Medicine(MNMD.US) With Buy Rating, Maintains Target Price $21
RBC Capital Remains a Buy on Mind Medicine (MNMD)
Mind Medicine Appoints Gregg Pratt Chief Regulatory, Quality Assurance Officer
Is Mind Medicine (MNMD) the Best Multibagger Stock to Buy Heading Into 2025?